Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Classement en actions #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Prix de l'action
$0.78611575
Capitalisation boursière
$60.45M
Changement (1 jour)
0.00%
Changement (1 an)
-12.06%
Pays
NO
Échange Lytix Biopharma AS (LYTIX)

Catégorie

Historique du prix de l'action pour Lytix Biopharma AS (LYTIX)
Prix de clôture le plus élevé : $0.83 le 2026-08-01

Prix de clôture le plus bas : $1.84 le 2021-06-01
Historique du prix de l'action de Lytix Biopharma AS de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$549.38 38.22%
US
$1.05K 58.78%
NL
$145.41 454.58%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH